NG2 proteoglycan promotes angiogenesis‐dependent tumor growth in the central nervous system by sequestering angiostatin
暂无分享,去创建一个
Olav Haraldseth | Rolf Bjerkvig | Martha Chekenya | Arthur Butt | O. Haraldseth | R. Bjerkvig | F. Thorsen | J. Levine | G. Pilkington | A. Butt | P. Enger | M. Hjelstuen | Frits Thorsen | Joel M Levine | Per Øyvind Enger | M. Chekenya | Mari Hjelstuen | Anne L Jacob | Beatrice Probst | Geoffrey Pilkington | A. Jacob | B. Probst | Per Øyvind Enger | Beatrice Probst | Anne L. Jacob
[1] J. Folkman,et al. Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.
[2] G. Breier,et al. Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*) , 1995, The Journal of Biological Chemistry.
[3] R Pasqualini,et al. NG2 proteoglycan-binding peptides target tumor neovasculature. , 1999, Cancer research.
[4] R. Bjerkvig,et al. Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro , 1999, Acta Neuropathologica.
[5] C. Heldin,et al. Co‐localization of NG2 proteoglycan and PDGF α‐receptor on O2A progenitor cells in the developing rat brain , 1996, Journal of neuroscience research.
[6] O Nalcioglu,et al. Measurement of vascular volume fraction and blood‐tissue permeability constants with a pharmacokinetic model: Studies in rat muscle tumors with dynamic Gd‐DTPA enhanced MRI , 1994, Magnetic resonance in medicine.
[7] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[8] W. Stallcup,et al. Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. , 1995, Experimental cell research.
[9] M. Raff. Glial cell diversification in the rat optic nerve. , 1989, Science.
[10] P. D’Amore,et al. Capillary growth: a two-cell system. , 1992, Seminars in Cancer Biology.
[11] W. Stallcup,et al. High-affinity Binding of Basic Fibroblast Growth Factor and Platelet-derived Growth Factor-AA to the Core Protein of the NG2 Proteoglycan* , 1999, The Journal of Biological Chemistry.
[12] A. Olivier,et al. NG2 immunoreactivity on human brain endothelial cells , 2001, Acta Neuropathologica.
[13] A. Nishiyama,et al. Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. , 1993, Molecular biology of the cell.
[14] F. Gage,et al. Proliferation and Differentiation of Progenitor Cells Throughout the Intact Adult Rat Spinal Cord , 2000, The Journal of Neuroscience.
[15] D. Ruiter,et al. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. , 1991, The American journal of pathology.
[16] G. Semenza. Transcriptional regulation by hypoxia-inducible factor 1 molecular mechanisms of oxygen homeostasis. , 1996, Trends in cardiovascular medicine.
[17] C. Lombardo,et al. Binding of the NG2 Proteoglycan to Kringle Domains Modulates the Functional Properties of Angiostatin and Plasmin(ogen)* , 2000, The Journal of Biological Chemistry.
[18] A. Nishiyama,et al. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. , 1997, Experimental cell research.
[19] I. Bernstein,et al. Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements. , 1996, Blood.
[20] M. Melamed,et al. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. , 1985, Cancer research.
[21] E. Keshet,et al. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.
[22] J. Levine. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[23] W. Stallcup,et al. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells , 1998, Journal of cellular physiology.
[24] J. Yuhas,et al. A simplified method for production and growth of multicellular tumor spheroids. , 1977, Cancer research.
[25] J. Prince,et al. The primary structure of NG2, a novel membrane-spanning proteoglycan , 1991, The Journal of cell biology.
[26] G. Yancopoulos,et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.
[27] S. Weiss,et al. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.
[28] W. Stallcup,et al. NG2 proteoglycan expression by pericytes in pathological microvasculature. , 2002, Microvascular research.
[29] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[30] M. Schrappe,et al. Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. , 1991, Cancer research.
[31] R. Reisfeld,et al. Inhibition of anchorage-independent growth of human melanoma cells by a monoclonal antibody to a chondroitin sulfate proteoglycan. , 1983, Journal of the National Cancer Institute.
[32] W. Stallcup,et al. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.
[33] R. Gillies,et al. Applications of magnetic resonance in model systems: tumor biology and physiology. , 2000, Neoplasia.
[34] D. Barritt,et al. Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. , 1999, Molecular biology of the cell.
[35] P A D'Amore,et al. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells , 1987, The Journal of cell biology.
[36] W. Stallcup,et al. Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[37] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[38] N. Kaplan,et al. Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[39] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[40] S Ferrone,et al. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. , 1989, The American journal of pathology.
[41] Jonas Frisén,et al. Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System , 1999, Cell.
[42] Y. Shoshan,et al. Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.